Detalhe da pesquisa
1.
Randomized multicenter phase 2 study of pomalidomide, cyclophosphamide, and dexamethasone in relapsed refractory myeloma.
Blood
; 127(21): 2561-8, 2016 05 26.
Artigo
em Inglês
| MEDLINE | ID: mdl-26932802
2.
Phase II study of pegylated liposomal doxorubicin, low-dose dexamethasone, and lenalidomide in patients with newly diagnosed multiple myeloma.
Am J Hematol
; 89(1): 62-7, 2014 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-24030918
3.
A Phase II Study to Determine the Safety and Efficacy of the Oral Inhibitor of Indoleamine 2,3-Dioxygenase (IDO) Enzyme INCB024360 in Patients with Myelodysplastic Syndromes.
Clin Lymphoma Myeloma Leuk
; 19(3): 157-161, 2019 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-30713125